Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Conference News ESC 2025

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD

L.A. McKeown

September 09, 2025

News Daily News

Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting

Caitlin E. Cox

December 17, 2024

News Daily News

Heart Failure and Cancer: HFSA Statement Explores the Interplay

Caitlin E. Cox

October 24, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

News Conference News ESC 2022

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

L.A. McKeown

August 26, 2022

News Daily News

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Michael O'Riordan

April 10, 2019

News Daily News

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

L.A. McKeown

December 01, 2016

News Daily News

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Michael O'Riordan

October 18, 2016

News Conference News ESC 2016

New Cardio-Oncology Position Statement Reviews Cardiovascular Side Effects of Cancer Therapies and Calls for Further Study

Shelley Wood

August 27, 2016

Presentation ESC 2016

Cancer Treatments And Cardiovascular Toxicity Developed Under The Auspices Of The ESC Committee for Practice Guidelines

Presenter: Patrizio Lancellotti

August 27, 2016

News Daily News

Primed Mesenchymal Stem Cells May Improve Heart Function

Caitlin E. Cox

April 12, 2013

Advertisement

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD

Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting

Heart Failure and Cancer: HFSA Statement Explores the Interplay

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

Vast Majority of HFrEF Patients Eligible for Vericiguat

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

New Cardio-Oncology Position Statement Reviews Cardiovascular Side Effects of Cancer Therapies and Calls for Further Study

Cancer Treatments And Cardiovascular Toxicity Developed Under The Auspices Of The ESC Committee for Practice Guidelines

Primed Mesenchymal Stem Cells May Improve Heart Function

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content